Jeffrey A. Tice
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jeffrey A. Tice has a total of 607 co-authors. Here are the top co-authors by number of shared publications:
- Karla Kerlikowske
Departments of Medicine and Epidemiology and Biostatistics, University of California, San Francisco, USA
34 shared publications - Diana L. Miglioretti
University of California, Davis 1 Department of Public Health Sciences Davis, California
31 shared publications - Brian L. Sprague
University of Vermont 3 Department of Surgery Burlington, Vermont
28 shared publications Karla Kerlikowske
General Internal Medicine Section, Department of Veteran Affairs and Departments of Medicine and Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California
25 shared publications- Charlotte C. Gard
Department of Economics, Applied Statistics, and International Business, New Mexico State University, Las Cruces, NM
19 shared publications Elad Ziv
University of California, San Francisco, San Francisco, USA
18 shared publications
Latest Publications
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S5 from Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer
Supplemental Figure S5 summarizes variable importance for random forests and gradient boosting using multiply imputed data.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S5 from Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer
Supplemental Figure S5 summarizes variable importance for random forests and gradient boosting using multiply imputed data.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table S1 from Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer
Supplemental Table S1 summarizes predictors included in the models.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S1 from Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer
Supplemental Table S1 summarizes predictors included in the models.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S1 from Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer
Supplemental Figure S1 illustrates the workflow of analyses for regression-based and machine learning methods.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S1 from Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer
Supplemental Figure S1 illustrates the workflow of analyses for regression-based and machine learning methods.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table S2 from Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer
Supplemental Table S2 summarizes variables in the multiple imputation model.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S2 from Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer
Supplemental Table S2 summarizes variables in the multiple imputation model.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table S3 from Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer
Supplemental Table S3 presents fraction of missing information and impact on the standard errors of performance metrics beyond 5 imputations.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S3 from Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer
Supplemental Table S3 presents fraction of missing information and impact on the standard errors of performance metrics beyond 5 imputations.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table S6 from Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer
Supplemental Table S6 presents variation in calibration metrics across racial/ethnic groups for each modeling approach.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S6 from Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer
Supplemental Table S6 presents variation in calibration metrics across racial/ethnic groups for each modeling approach.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table S5 from Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer
Supplemental Table S5 summarizes calibration metrics, stratified by racial and ethnic group.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S5 from Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer
Supplemental Table S5 summarizes calibration metrics, stratified by racial and ethnic group.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure S3 from Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer
Supplemental Figure S3 presents screening interval-stratified model calibration for advanced cancer by three metrics: the ratio of expected and observed events (E/O ratio), the calibration intercept, and the calibration slope.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure S3 from Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer
Supplemental Figure S3 presents screening interval-stratified model calibration for advanced cancer by three metrics: the ratio of expected and observed events (E/O ratio), the calibration intercept, and the calibration slope.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table S8 from Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer
Supplemental Table S8 presents sensitivity, specificity, positive predictive value, and negative predictive value for various risk modeling approaches, stratified by screening interval.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S8 from Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer
Supplemental Table S8 presents sensitivity, specificity, positive predictive value, and negative predictive value for various risk modeling approaches, stratified by screening interval.
- Open Access
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table S7 from Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer
Supplemental Table S7 summarizes area under the receiver operating characteristic curve (AUC) for various risk modeling approaches, stratified by menopausal status and screening interval.
- 3 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table S7 from Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer
Supplemental Table S7 summarizes area under the receiver operating characteristic curve (AUC) for various risk modeling approaches, stratified by menopausal status and screening interval.